Urology Search
Urology Urology
overactive%20bladder
OVERACTIVE BLADDER

Overactive bladder or non-neurogenic overactive bladder is a syndrome characterized by urinary urgency, frequency, nocturia and urgency incontinence.
It is not a disease but a symptom complex that generally is not a life-threatening condition. It is also known as bladder spasms.
Urgency is the complaint of sudden, compelling desire to pass urine that is difficult to deny. It is considered a hallmark symptom of overactive bladder.
Frequency is usually micturition of >7 episodes during waking hours.
Nocturia is the interruption of sleep one or more times because of the need to void.
Urgency incontinence is the involuntary leakage of urine associated with a sudden compelling desire to void.

Surgical Intervention

InterStim Therapy
  • Used in patients with urinary urgency, frequency, urge incontinence and retention
  • A small device implanted under the skin of one of the upper buttocks
  • Works by gently stimulating the sacral nerves to help the bladder function normally
Augmentation Cystoplasty
  • Small piece of tissue from the intestine is added to the wall of the bladder to increase the size of the bladder
  • Done by opening the abdomen and sometimes through the use of laparoscope
  • Consider in patients with non-progressive neurological disorders and impaired bladder storage
Urinary Diversion
  • Procedure is only done if all other options have failed to treat overactive bladder (OAB) symptoms
  • Tubes from the kidneys to the bladder and ureters are routed directly to the outside of your body
Nerve Stimulation
 Sacral nerve stimulation
  • Small pulse generator is implanted under the skin of the buttock to send electrical signals to the nerves that control the bladder
Peroneal nerve stimulation
  • Another pulse generator used to stimulate the nerves controlling the bladder
Editor's Recommendations
Most Read Articles
Ivermectin improves survival in COVID-19 patients with severe pulmonary involvement
4 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
Mental health problems spell trouble for diabetics
4 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Empagliflozin not just another SGLT2i: Cardio-renal benefits extend to HF with or without diabetes
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Vitamin D deficient COVID-19 patients at risk of morbidity, mortality
Yesterday
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.